Overview

Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

Status:
Withdrawn
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Tacrolimus Treatment of patients with idiopathic focal segmental glomerulosclerosis.
Phase:
N/A
Details
Lead Sponsor:
Nanjing University School of Medicine
Treatments:
Tacrolimus